About Us

GEUS Technology

Aniling owns the GEUS technology, which unifies genetic and epigenetic sequencing and provides end-to-end solutions for the right treatment decisions in oncology. Based on GEUS, Aniling is developing a set of products for cancer diagnostic.


The first Aniling product is the most comprehensive Chronic Lymphocytic Leukemia Next Generation Sequencing diagnostics panel. The GEUS-CLL delivers accurate staging and treatment decisions. Aniling S.L. provides the GEUS-CLL diagnostic test as a service to other laboratories and hospitals.

Latest News

gummy sequencing by MAP

DNA Day 2023

Let’s take a moment to celebrate two remarkable milestones in science. Today marks the 70th anniversary of the discovery of the DNA double helix and the 20th anniversary of the …

CRC day by Freepik

Today is World Colorectal Cancer Day

On World Colorectal Cancer Day, we want to shed light on the importance of early detection and treatment of this global health challenge. Colorectal cancer is the third most common …